524 related articles for article (PubMed ID: 21300462)
1. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Välimäki P; Mäkitie A; Seppänen M; Minn H; Revitzer H; Kouri M; Kotiluoto P; Seren T; Auterinen I; Savolainen S; Joensuu H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e67-75. PubMed ID: 21300462
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
[TBL] [Abstract][Full Text] [Related]
3. Boron Neutron Capture Therapy in the Treatment of Recurrent Laryngeal Cancer.
Haapaniemi A; Kankaanranta L; Saat R; Koivunoro H; Saarilahti K; Mäkitie A; Atula T; Joensuu H
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):404-410. PubMed ID: 26797537
[TBL] [Abstract][Full Text] [Related]
4. Fractionated Boron Neutron Capture Therapy in Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial.
Wang LW; Chen YW; Ho CY; Hsueh Liu YW; Chou FI; Liu YH; Liu HM; Peir JJ; Jiang SH; Chang CW; Liu CS; Lin KH; Wang SJ; Chu PY; Lo WL; Kao SY; Yen SH
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):396-403. PubMed ID: 27084657
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival.
Koivunoro H; Kankaanranta L; Seppälä T; Haapaniemi A; Mäkitie A; Joensuu H
Radiother Oncol; 2019 Aug; 137():153-158. PubMed ID: 31108276
[TBL] [Abstract][Full Text] [Related]
6. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
7. Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors.
Suzuki M; Sakurai Y; Nagata K; Kinashi Y; Masunaga S; Ono K; Maruhashi A; Kato I; Fuwa N; Hiratsuka J; Imahori Y
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1523-7. PubMed ID: 17056200
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
12. Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis.
Ariyoshi Y; Miyatake S; Kimura Y; Shimahara T; Kawabata S; Nagata K; Suzuki M; Maruhashi A; Ono K; Shimahara M
Oncol Rep; 2007 Oct; 18(4):861-6. PubMed ID: 17786347
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of BNCT for recurrent head and neck malignancies.
Kato I; Ono K; Sakurai Y; Ohmae M; Maruhashi A; Imahori Y; Kirihata M; Nakazawa M; Yura Y
Appl Radiat Isot; 2004 Nov; 61(5):1069-73. PubMed ID: 15308194
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
16. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
17. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
18. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
20. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
